Menu ×

HEALTHCARE & PHARMACEUTICAL

Narcotics Analgesics Market Analysis by Type (Non-Opioids, and Opioids); by Application (Pain Management, Cough Treatment, and Diarrhea); and by Administration Route (Oral, Intravenous, Rectal, Transdermal, and Topical) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2035

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More

IN THE NEWS

  •  Johnson & Johnson Services, Inc. announced a settlement agreement with the State of New York and its subdivisions, resolving their opioid-related claims against the Company. The settlement will provide about USD 263 million in funding for New York and its subdivisions to address opioid-related issues and as reimbursement for attorney fees and costs.

  • AbbVie Inc. in association with Neurocrine Biosciences, Inc. announced the release of first and only gonadotropin-releasing hormone ORILISSA that has been approved by the U.S Food and Drug Administration.

Global Narcotics Analgesics Market Size, Forecast, and Trend Highlights Over 2023 - 2035

Base Year

2023

Forecast Year

2023-2035

CAGR

~5%

Base Year Market Size (2023)

~ USD 27 Billion

Forecast Year Market Size (2035)

~ USD 51 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)

 

The global narcotics analgesics market is estimated to garner a revenue of ~USD 51 Billion by the end of 2035 by growing at a CAGR of ~5% over the forecast period, i.e., 2023 – 2035. Further, the market generated a revenue of ~USD 27 Billion in the year 2023. The growth of the market can be attributed to an increment in the research and development of narcotics analgesics worldwide. Further, the increased use of heroin, a type of narcotic analgesic, is also expected to contribute to market growth. In 2019, more than 40,000 people tried heroin for the first time and in 2020, around 7,00,000 people used heroin. Besides this, the rise in concern for the misuse of pain killers and the myth that pure heroin is less harmful than less pure heroin forms is also poised to create numerous opportunities for market growth in the coming years. Also, a growing tolerance to non-narcotics analgesics is the major reason for the constant increase in sales of narcotics analgesics.

narcotics market overview image

Get more information on this report:Download Sample PDF

The growth of the global narcotics analgesics market can also be attributed to the quick onset of action of these pharmaceutical drugs and the high efficiency of these drugs for neuropathic pain management. In addition to this, the rise in demand for drugs for pain relief related to the central nervous system (CNS), such as morphine, is also anticipated to drive market growth. International Narcotics Control Board reported that 79% of the world’s population consumed 13% of morphine used for the management of pain and suffering or 1% out of 388.2 tons of total morphine manufactured across the world.

Global Narcotics Analgesics Market: Growth Drivers and Challenges

Growth Drivers

  • Increased Research for Cancer Treatment DrugsAs per the National Cancer Institute the funding for cancer research increased from USD 4,952.6 in 2015 to USD 6,440.4 in 2019.

  • Increase in Incidence of Chronic Diseases such as Cancer, Heart Disorders, Arthritis, and Tuberculosis – The unhealthy lifestyle has led to an increase of chronic diseases among the population. As a result of rising diagnosis of high number of chronic diseases is expected to increase the adoption of narcotics analgesics in the healthcare sector. About 60 million adults have arthritis in the U.S, which is about 1 in 4 adults.

  • Rising Consumption of Different Types of DrugsIn the year 2020, the use of different types of drugs increased by more than 20% from 2010 during the COVID-19 pandemic.

  • Increasing Dispensing Rates of Opioids – In 2020, over 3% of U.S countries dispensed adequate opioid prescriptions for every individual to have one. Further, the overall dispensing rate in the U.S in the same year was over 40 prescriptions per 100 people, while some countries had nine times higher rates.

  • Government Support to Improve Pharmaceutical and Analgesic IndustriesThe estimated R&D expenditure in the pharmaceutical industry in 2019 was more than USD 80 billion.

  • Growth of Geriatric Population Who Uses Painkillers – As per the United Nations Department of Economic and Social Affairs, globally, 703 million people were aged over 65 years in 2019. The share of the population aged over 65 years had increased from 6% in 1999 to 9% in 2019 across the globe.

Challenges

  • Shortage of Analgesic Medication

  • Imposed Regulations to Prevent Misuse

  • Addiction to Narcotics Drugs – Narcotics drugs such as heroines can be highly addictive if consumed once. The addiction can further push individuals into serious disorders like substance abuse in the longer run.

The global narcotics analgesics market is segmented and analyzed for demand and supply by administration route into oral, intravenous, rectal, transdermal, and topical, out of which, the oral segment is anticipated to hold the largest market share by the end of 2031. The growth of the segment can be attributed to the simple administration through the oral route, the non-invasive nature of administration, and the increased efficiency of these drugs when compared to other routes of administration. Over 80% of drugs in high demand are oral route products with a value of USD 30 billion and a growth rate of 10% annually. 

Global Narcotics Analgesics Market Regional Synopsis

The North America narcotics analgesics market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035, on the back of an increase in demand for pain killers. The rise in diseases and chronic illnesses is expected to bolster the sales of narcotics analgesics in the region. Between 2015-2018 about 10.7% of U.S adults aged 20 and above used one or more prescription pain medications (opioid or nonopioid) and 5.7% used one or more prescription opioids, as per the statistics by the Centers for Disease Control and Prevention (CDC).

Market Segmentation

Our in-depth analysis of the global narcotics analgesics market includes the following segments:

       By Type

  • Non-opioids
  • Opioids

      By Application

  • Pain Management
  • Cough Treatment
  • Diarrhea

     By Administration Route

  • Oral
  • Intravenous
  • Rectal
  • Transdermal
  • Topical

Top Featured Companies Dominating the Global Narcotics Analgesics Market

  • Pfizer Inc.

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Abbott Laboratories
  • Janssen Global Services, LLC
  • Novartis AG
  • Bayer AG
  • GlaxoSmithKline plc

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved